98 related articles for article (PubMed ID: 19860582)
1. Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides.
Wang H; Yang J; Jin L; Feng J; Lu Y; Sun Y; Li T; Cao R; Wu J; Fan H; Liu J
Immunol Invest; 2009; 38(8):690-703. PubMed ID: 19860582
[TBL] [Abstract][Full Text] [Related]
2. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
[TBL] [Abstract][Full Text] [Related]
4. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.
Gong Z; Long X; Pan L; Le Y; Liu Q; Wang S; Guo J; Xiao B; Zhou M; Mei D
Protein Expr Purif; 2009 Aug; 66(2):191-7. PubMed ID: 19364533
[TBL] [Abstract][Full Text] [Related]
6. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.
Gong Z; Jin Y; Zhang Y
Vaccine; 2007 Feb; 25(8):1444-51. PubMed ID: 17113687
[TBL] [Abstract][Full Text] [Related]
7. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
Maron R; Melican NS; Weiner HL
J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
[TBL] [Abstract][Full Text] [Related]
8. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes.
Gong Z; Jin Y; Zhang Y
J Biotechnol; 2005 Sep; 119(1):93-105. PubMed ID: 16024127
[TBL] [Abstract][Full Text] [Related]
10. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
11. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
Joussemet B; Vu AT; Sai P; Bach JM
Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccination with glutamic acid decarboxylase (GAD) generates a strong humoral immune response in BALB/c, C57BL/6, and in diabetes-prone NOD mice.
Wiest-Ladenburger U; Fortnagel A; Richter W; Reimann J; Boehm BO
Horm Metab Res; 1998 Oct; 30(10):605-9. PubMed ID: 9851666
[TBL] [Abstract][Full Text] [Related]
13. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes.
Arakawa T; Yu J; Chong DK; Hough J; Engen PC; Langridge WH
Nat Biotechnol; 1998 Oct; 16(10):934-8. PubMed ID: 9788349
[TBL] [Abstract][Full Text] [Related]
14. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice.
Zechel MA; Elliott JF; Atkinson MA; Singh B
J Autoimmun; 1998 Feb; 11(1):83-95. PubMed ID: 9480726
[TBL] [Abstract][Full Text] [Related]
15. Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses.
Dénes B; Yu J; Fodor N; Takátsy Z; Fodor I; Langridge WH
Mol Biotechnol; 2006 Nov; 34(3):317-27. PubMed ID: 17284779
[TBL] [Abstract][Full Text] [Related]
16. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.
Presa M; Ortiz AZ; Garabatos N; Izquierdo C; Rivas EI; Teyton L; Mora C; Serreze D; Stratmann T
Eur J Immunol; 2013 Nov; 43(11):2969-79. PubMed ID: 23925934
[TBL] [Abstract][Full Text] [Related]
17. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
Bockova J; Elias D; Cohen IR
J Autoimmun; 1997 Aug; 10(4):323-9. PubMed ID: 9237795
[TBL] [Abstract][Full Text] [Related]
18. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.
Boberg A; Gaunitz S; Bråve A; Wahren B; Carlin N
Vaccine; 2008 Sep; 26(40):5079-82. PubMed ID: 18514370
[TBL] [Abstract][Full Text] [Related]
20. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis.
Carter JE; Yu J; Choi NW; Hough J; Henderson D; He D; Langridge WH
Mol Biotechnol; 2006 Jan; 32(1):1-15. PubMed ID: 16382177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
